The First Affiliated Hospital of Bengbu Medical University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

2 drugs in development

Phase 21

Phase 11

By Therapeutic Area

top 2

Oncology

150%

Metabolic & Endocrine

150%

R&D Momentum

43/100

Pipeline Velocity

22/100

Trial Completion Rate

N/A

Pipeline Concentration

50/100

Pipeline Freshness

59/100

Strategic Signals

↗Active in Oncology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Enrolling by invitation

Study on the Efficacy and Safety of Non-Invasive Brain-Computer Interface With MRI-Guided Multi-Channel Time-Domain Interference Stimulation in Treating Motor Dysfunction in Acute Cerebral Infarction Patients

Oct 24, 2026

Recruiting

A Prospective, Single-Arm, Exploratory Clinical Study of Vebreltinib Antibody-Drug Conjugate (EGFR-ADC) in Combination With Investigator-Selected Immune Checkpoint Inhibitors and Multimodal Radiotherapy for Second-Line and Beyond Treatment of Advanced Esophageal Squamous Cell Carcinoma

Earlier

Sep 29, 2026TrialMechanistic Study on Brain-Computer Interface-Based Dual-Target Neurofeedback Training Intervention for Cognitive Control Deficits in Internet Gaming Disorder

Sep 9, 2026TrialA Prospective Study of the Efficacy and Safety of Apatinib Monotherapy as First-Line Treatment in Elderly Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Sep 5, 2026TrialA Prospective Study to Assess Both Thyroid Abnormity Incidence In Chinese Women With Newly Diagnosed Breast Cancer and Thyroid Toxicity of Breast Cancer Patients Undergoing Chemotherapy

Sep 5, 2026TrialA Prospective, Randomized, Open Label Clinical Study Evaluating Efficacy and Safety of Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic Triple Negative Breast Cancer

Sep 4, 2026TrialA Phase II, Single-Arm, Open-Label, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Apatinib in Patients With Refractory Malignant Ascites

Aug 7, 2026TrialA Clinical Study for the Safety and Efficacy of IV Infusion of NGGT002 in the Treatment of Phenylketonuria

4 more events

Jul 23, 2026TrialMechanisms and Interventions of Social Reward Modulating Cognitive Control in Internet Gaming Disorder Via the dACC-DLPFC Circuit

Dec 20, 2025TrialAn Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer

Apr 1, 2024TrialClinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

Mar 30, 2024TrialEfficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma